Arch Biopartners Releases Inflammatory Enzymes, Bowel Disease Study

Arch Biopartners has announced the release of a study linking the caspase 1 enzyme to inflammatory bowel disease that was published in the Inflammatory Bowel Diseases journal.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The full “Epithelial Cell Extrusion Leads to Breaches in the Intestinal Epithelium” study can be found here.

Arch Biopartners is a Toronto, Ontario-based technology company.

More Articles on Gastroenterology:
Apollo Endosurgery Receives CE Mark for Endoscopic Suturing Device
UW Health Opens $21M Digestive Center in Madison
Colon Cancer Challenge Foundation, Physicians Endoscopy Partner

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.